ATOS · Atossa Therapeutics, Inc. · Suppliers & Customers
$1.65
-0.10 (-5.71%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2023 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20
48.93K
Avg daily vol (3M)
67.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones ATOS names, and the companies that name ATOS.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who ATOS sells to, buys from and competes with
- 1 supplier
- 0 customers
- 1 competitor
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
61 filings
35 filers
Visit website
Investor relations